BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31441020)

  • 1. Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours.
    Dos Santos Passaia B; Lima K; Kremer JL; da Conceição BB; de Paula Mariani BM; da Silva JCL; Zerbini MCN; Fragoso MCBV; Machado-Neto JA; Lotfi CFP
    Invest New Drugs; 2020 Jun; 38(3):899-908. PubMed ID: 31441020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.
    Aronova A; Min IM; Crowley MJP; Panjwani SJ; Finnerty BM; Scognamiglio T; Liu YF; Whitsett TG; Garg S; Demeure MJ; Elemento O; Zarnegar R; Fahey TJ
    Ann Surg Oncol; 2018 Mar; 25(3):792-800. PubMed ID: 29214451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinoma.
    Ni PZ; He JZ; Wu ZY; Ji X; Chen LQ; Xu XE; Liao LD; Wu JY; Li EM; Xu LY
    Oncol Rep; 2017 Dec; 38(6):3608-3618. PubMed ID: 29039594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Assessment of
    Mohan DR; Lerario AM; Else T; Mukherjee B; Almeida MQ; Vinco M; Rege J; Mariani BMP; Zerbini MCN; Mendonca BB; Latronico AC; Marie SKN; Rainey WE; Giordano TJ; Fragoso MCBV; Hammer GD
    Clin Cancer Res; 2019 Jun; 25(11):3276-3288. PubMed ID: 30770352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer.
    Laha D; Grant RRC; Mishra P; Boufraqech M; Shen M; Zhang YQ; Hall MD; Quezado M; De Melo MS; Del Rivero J; Zeiger M; Nilubol N
    J Exp Clin Cancer Res; 2022 Sep; 41(1):282. PubMed ID: 36151566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.
    Fu Y; Sun S; Bi J; Kong C; Yin L
    Medicine (Baltimore); 2021 Mar; 100(10):e25031. PubMed ID: 33725886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
    Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Zhu Y; Zhang Z; Kong C
    Oncol Rep; 2019 Apr; 41(4):2440-2452. PubMed ID: 30816525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
    Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
    Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.
    Bao P; Yokobori T; Altan B; Iijima M; Azuma Y; Onozato R; Yajima T; Watanabe A; Mogi A; Shimizu K; Nagashima T; Ohtaki Y; Obayashi K; Nakazawa S; Bai T; Kawabata-Iwakawa R; Asao T; Kaira K; Nishiyama M; Kuwano H
    Ann Surg Oncol; 2017 Dec; 24(13):4017-4024. PubMed ID: 28933054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma.
    Korah R; Healy JM; Kunstman JW; Fonseca AL; Ameri AH; Prasad ML; Carling T
    Mol Cancer; 2013 Aug; 12():87. PubMed ID: 23915220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
    Buishand FO; Liu-Chittenden Y; Fan Y; Tirosh A; Gara SK; Patel D; Meerzaman D; Kebebew E
    Surgery; 2020 Jan; 167(1):224-232. PubMed ID: 31522749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data.
    Xu N; Ke ZB; Lin XD; Lin F; Chen SH; Wu YP; Chen YH; Wei Y; Zheng QS
    Aging (Albany NY); 2020 Mar; 12(6):4996-5009. PubMed ID: 32217810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis.
    Yang Z; Cheng H; Zhang Y; Zhou Y
    Med Sci Monit; 2021 Mar; 27():e928523. PubMed ID: 33667214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication.
    Lippert J; Appenzeller S; Liang R; Sbiera S; Kircher S; Altieri B; Nanda I; Weigand I; Gehrig A; Steinhauer S; Riemens RJM; Rosenwald A; Müller CR; Kroiss M; Rost S; Fassnacht M; Ronchi CL
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4511-4523. PubMed ID: 30113656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of prognostic metabolic genes in adrenocortical carcinoma and establishment of a prognostic nomogram: A bioinformatic study.
    Chen Q; Ren Z; Liu D; Jin Z; Wang X; Zhang R; Liu Q; Cheng W
    Medicine (Baltimore); 2021 Dec; 100(50):e27864. PubMed ID: 34918636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HOTAIR participates in the development and progression of adrenocortical carcinoma via regulating cell cycle.
    Yan ZC; He L; Qiu JH; Deng WT; Lu JR; Yuan Z; Liu DJ; Zheng RQ; Jiang W
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6640-6649. PubMed ID: 30402836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stathmin 1 is a potential novel oncogene in melanoma.
    Chen J; Abi-Daoud M; Wang A; Yang X; Zhang X; Feilotter HE; Tron VA
    Oncogene; 2013 Mar; 32(10):1330-7. PubMed ID: 22665054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
    Wang S; Akhtar J; Wang Z
    Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circ-CCAC1 Facilitates Adrenocortical Carcinoma Cell Proliferation, Migration, and Invasion through Regulating the miR-514a-5p/C22orf46 Axis.
    Li W; Liu R; Wei D; Zhang W; Zhang H; Huang W; Hao L
    Biomed Res Int; 2020; 2020():3501451. PubMed ID: 33195693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.